Technical Aspects of Licensing an antibiotic

Event contact first name
Daniel
Event contact last name
Lee
Email
dlee@smi-online.co.uk
Event contact telephone number
+44 (0) 20 7827 6078
Description

Learn what are the key R&D-related elements involved in the inward or outward licensing of antibiotics. Join SMi as this Masterclass will cover an outline of the licensing process, what technical data is needed as part of a product licensing prospectus, what Big pharma looks for and the product evaluation and due diligence processes Antibiotic resistance is a serious and growing threat in contemporary medicine, emerging as one of the pre-eminent public health concerns of the 21st century. Some 125,000 people across Europe and the USA suffer every year due to bacterial infections resistant to antibiotic treatments. Within these regions, drug-resistant bacteria inflict an additional financial burden on healthcare systems through exaggerated medical costs of up to $35 billion. Why should you attend? Anyone likely to be involved in the preparation of scientific material for an outward license or in evaluating inward licensing opportunities will benefit from this workshop, which will cover all the key scientific drivers and issues that need to be considered. This Masterclass will be hosted by: David Scott, Consultant, PharmaConsulting For full conference programme please visit: www.smi-online.co.uk/antibiotic-license2.asp For more information please contact: Daniel Lee on +44 (0) 207 827 6078 or email at dlee@smi-online.co.uk

Partner Voices

Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.